Filamin-A-Related Myxomatous Mitral Valve Dystrophy: Genetic, Echocardiographic and Functional Aspects

A. Lardeux, Vincent Probst(Centre National de la Recherche Scientifique), Florence Kyndt(Inserm), Hervé Le Marec(Centre National de la Recherche Scientifique), Simon Lecointe(Centre National de la Recherche Scientifique), Jean Mérot, Thierry Le Tourneau(Centre National de la Recherche Scientifique), Jean‐Jacques Schott(Centre National de la Recherche Scientifique)
Journal of Cardiovascular Translational Research
July 19, 2011
10.1007/s12265-011-9308-9
Cited by 48

Related Papers

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
|Heart Rhythm|2011|1.5k
Congenital Heart Disease Caused by Mutations in the Transcription Factor <i>NKX2-5</i>
|Science|1998|1.3k
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death
|Nature|2003|961
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
|EP Europace|2011|904
Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome
|Circulation|2010|850